Ann M. Veneman is Director at ALEXION PHARMACEUTICALS INC (ALXN). They have made 8 open-market trades across 1 company since 2012, most recently 2024-02-19.
CIK 0001493023
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALXN | SELL | 2017-09-05 | 2017-09-05 | $145.81 | $244K | +1.1% | -0.9% | -23.0% |
| ALXN | SELL | 2017-07-31 | 2017-08-02 | $137.74 | $96K | -3.0% | +4.3% | -13.4% |
| ALXN | SELL | 2015-12-11 | 2015-12-15 | $187.48 | $168K | -15.6% | -10.5% | -28.1% |
| ALXN | SELL | 2014-12-11 | 2014-12-15 | $193.03 | $238K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2014-06-04 | 2014-06-06 | $170.01 | $210K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2013-04-29 | 2013-05-01 | $99.00 | $308K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2012-12-12 | 2012-12-14 | $95.00 | $435K | -15.6% | -1.2% | -1.2% |
| ALXN | SELL | 2012-02-17 | 2012-02-21 | $81.10 | $162K | -15.6% | -1.2% | -1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.